Allerfen 180 mg 20 tablets

Tradename

Allerfen

Composition

Each film-coated tablet contains 180 mg of fexofenadine hydrochloride.

Auxiliary components: lactose, microcrystalline cellulose, colloidal silicon dioxide, povidonec30, crospovidone, talc, magnesium stearate, pink opadrium.

Pharmacological group:

antiallergic agent, blocker of HI-histamine receptors.

Pharmacological properties:

Fexofenadine is the active metabolite of terfenadine. After a single or 2-fold administration, the drug exhibits an antihistamine effect, starting from 1 hour, reaching a maximum effect after 6 hours and continuing for 24 hours. Has no sedative effect. There was no evidence of habituation to these effects after 28 days of dosing.

Indications

Elimination of symptoms associated with seasonal allergic rhinitis and uncomplicated cutaneous manifestations of chronic idiopathic urticaria.

Dosing regimen:

for adults and children aged 12 years and older, the recommended dose is 180 mg 1 time per day before meals.

Side effects

Fexofenadine is generally well tolerated. The most frequently (1-10% of cases) reported headache, fatigue, dizziness or drowsiness, and nausea. In placebo-controlled studies with a frequency of less than 1%, weakness, insomnia, nervousness, sleep disturbance, tachycardia, palpitations, diarrhea were noted. In rare cases (less than 0.1%), exanthema, urticaria, itching, Quincke’s edema, difficulty breathing, shortness of breath, skin redness, anaphylactic reactions were observed.

Drug interaction:

concomitant use with ketoconazole and erythromycin may cause an increase in plasma concentration of fexofenadine. An antacid containing aluminum and magnesium can reduce the absorption of fexofenadine, the recommended interval between doses of these substances should be at least 2 hours.

Storage

Store at a temperature not exceeding 30 C dry place out of the reach of children.

Packaging:

tablets 180mg, in a package of 1,2,3 blisters of 10 tablets.